Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RX-10045 for Dry Eye Syndrome
NCT00799552Phase 2Completed
- Sponsor
- Resolvyx Pharmaceuticals
- Start
- Nov 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of navamepent in dry eye syndrome (DED), sponsored by Resolvyx Pharmaceuticals. Started Nov 2008; status: completed.
02
Drugs
navamepent
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00799552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799552.